Linking cancer genome to proteome: NCI's investment into proteogenomics
暂无分享,去创建一个
Mehdi Mesri | Henry Rodriguez | Christopher Kinsinger | Tara Hiltke | Robert C Rivers | Emily S Boja
[1] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[2] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[3] Ronald J Moore,et al. Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels* , 2014, Molecular & Cellular Proteomics.
[4] Christoph H Borchers,et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.
[5] David L. Tabb,et al. Performance Metrics for Liquid Chromatography-Tandem Mass Spectrometry Systems in Proteomics Analyses* , 2009, Molecular & Cellular Proteomics.
[6] Jeffrey R. Whiteaker,et al. Proteogenomic characterization of human colon and rectal cancer , 2014, Nature.
[7] Mehdi Mesri,et al. Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. , 2013, Cancer discovery.
[8] Bing Zhang,et al. NetGestalt: integrating multidimensional omics data over biological networks , 2013, Nature Methods.
[9] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[10] Birgit Schilling,et al. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. , 2010, Journal of proteome research.
[11] Birgit Schilling,et al. Interlaboratory Study Characterizing a Yeast Performance Standard for Benchmarking LC-MS Platform Performance* , 2009, Molecular & Cellular Proteomics.